title: [Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].
abstract: The glycosphingolipids globotrihexosylceramide (Gb3, CD77) and isoglobotrihexosylceramide (iGb3) are isomers differing only in one glycosidic bond and have been implicated in several processes of the innate and adaptive immune system.
  
  
  OBJECTIVE
  1) To verify the function of Gb3 in the pathogenesis of hemolytic-uremic syndrome as the cellular receptor responsible for cytotoxicity caused by verotoxin (VT) elaborated by Shigella and certain strains of E.coli. 2) To investigate in vivo the previously implicated function of iGb3 as the endogenous lipid ligand responsible for positive selection of invariant natural killer T-cells (iNKT), which have an essential regulatory function in infection, tumor rejection and tolerance.
  
  
  METHODS
  Generation of mice deficient in Gb3 and iGb3 synthesizing enzymes and VT injection into Gb3-deficient mice. Analysis of iNKT cell development and function by flow cytometry and by administration of the exogenous agonist alpha-galactosylceramide in iGb3-deficient mice.
  
  
  RESULTS
  For 1) Gb3-deficient mice were insensitive to otherwise lethal doses of VT, and 2) iGb3-deficient mice showed normal numbers of iNKT cells. Furthermore the function of iNKT cells evolving in iGb3-deficient mice was unaffected.
  
  
  CONCLUSIONS
  1) Gb3 is the cellular receptor mediating verotoxin cytotoxicity in haemolytic-uremic syndrome. 2) In contrast to previous indirect implications, iGb3 cannot be regarded as an endogenous ligand responsible for the positive selection of iNKT cells.
authors.affiliation: Zelluläre und molekulare Pathologie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120 Heidelberg. s.porubsky@dkfz.de
authors.forename: S
authors.initials: S
authors.lastname: Porubsky
authors.forename: B
authors.initials: B
authors.lastname: Luckow
authors.forename: M
authors.initials: M
authors.lastname: Bonrouhi
authors.forename: A
authors.initials: A
authors.lastname: Speak
authors.forename: V
authors.initials: V
authors.lastname: Cerundolo
authors.forename: F
authors.initials: F
authors.lastname: Platt
authors.forename: H-J
authors.initials: HJ
authors.lastname: Gröne
mesh_terms: D000818:Animals; D016207:Cytokines / Q000097:blood; D003713:Dendritic Cells / Q000276:immunology; D004926:Escherichia coli / Q000276:immunology; D005260:Female; D005915:Globosides / Q000235:genetics / Q000502:physiology*; D006463:Hemolytic-Uremic Syndrome / Q000276:immunology*; D018655:Lymphocyte Count; D051379:Mice; D018345:Mice, Knockout; D055611:Natural Killer T-Cells / Q000276:immunology*; D022603:Shiga Toxins / Q000276:immunology / Q000633:toxicity; D012760:Shigella / Q000276:immunology; D014281:Trihexosylceramides / Q000235:genetics / Q000502:physiology*
chemical_list: D016207:Cytokines; D005915:Globosides; D022603:Shiga Toxins; D014281:Trihexosylceramides; C018549:globotriaosylceramide; C037097:isoglobotriaosylceramide